Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine von Modjarrad, Kayvon, Che, Ye, Chen, Wei, Wu, Huixian, Cadima, Carla I., Muik, Alexander, Maddur, Mohan S., Tompkins, Kristin R., Martinez, Lyndsey T., Cai, Hui, Ramos, Minah, Mensah, Sonia, Cumbia, Brittney, Falcao, Larissa, McKeen, Andrew P., Chang, Jeanne S., Fennell, Kimberly F., Huynh, Kevin W., McLellan, Thomas J., Sahasrabudhe, Parag V., Chen, Wei, Cerswell, Michael, Garcia, Miguel A., Li, Shilong, Sharma, Rahul, Li, Weiqiang, Dizon, Kristianne P., Duarte, Stacy, Gillett, Frank, Smith, Rachel, Illenberger, Deanne M., Efferen, Kari Sweeney, Vogel, Annette B., Anderson, Annaliesa S., Şahin, Uğur, Swanson, Kena A.

Volltext